Map showing total medical and indirect societal cost
Map showing percentage of people living with diabetes
Novo Nordisk believes that good public policy can move the U.S. forward in lessening the burden and impact of diabetes in America. Learn about initiatives designed to place diabetes higher on the nation’s agenda.
The Novo Nordisk U.S. Diabetes Barometer serves as a tool to help inform key
stakeholders and policymakers of the magnitude
of the diabetes epidemic through the Measure,
Share, Improve mindset.